Endodontic Inflammation, Operative Dentistry, Pulpitides, Toothaches
Conditions
Brief summary
The objective of the study is to determine which of the two commonly used endodontic medications (Eugenol VS Articaine) is most effective in controlling postoperative pain in irreversible pulpitis of the mature permanent tooth in adults. To do so, an assessment of the pain felt by patients will be carried out a few days apart. The supposed results are that the medications are equivalent in terms of effectiveness on the pain, but could then present different economic arguments
Detailed description
In irreversible pulpitis of the mature permanent tooth, the enrolled patients receive endodontic medications (Eugenol or Articaine) in order to determine which one is the more efficient to control the pain. These patients would have received the same medication without this study. That's why this is an obsevationnal study.
Interventions
DRUGImplementation of a pulp medication in compliance with the dental emergency management protocol: articaïne
Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne
DRUGImplementation of a pulp medication in compliance with the dental emergency management protocol: eugenol
Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol
Sponsors
University Hospital, Strasbourg, France
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult patient, major, affiliated to a social health insurance scheme * Patient having agreed to participate in the study * Urgent consultant patient for irreversible pulpitis * Patient understanding French
Exclusion criteria
* Refusal of the patient to participate in the study * Impossibility of performing the surgical procedure * Impossibility to give the subject information enlightened (difficulty of understanding ...) * Subject under the protection of justice, or under guardianship * General contraindication to endodontic treatment in 2 sessions (high risk of infectious endocarditis, for example) * Chronic intake of analgesic drugs
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain evolution (decrease or increase the intensity of the pain) | 7 days | Evolution of pain (using a score of 0 to 10) |
Countries
France
Outcome results
None listed